SOLID ORGAN TRANSPLANT COMPLICATIONS
Clinical trials for SOLID ORGAN TRANSPLANT COMPLICATIONS explained in plain language.
Never miss a new study
Get alerted when new SOLID ORGAN TRANSPLANT COMPLICATIONS trials appear
Sign up with your email to follow new studies for SOLID ORGAN TRANSPLANT COMPLICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy offers hope for transplant patients with rare Virus-Driven cancer
Disease control Recruiting nowThis study is testing an experimental cell therapy called tabelecleucel for transplant patients who develop a rare cancer caused by Epstein-Barr virus. The treatment uses specially prepared immune cells to target and fight the virus-related cancer in patients who haven't responde…
Matched conditions: SOLID ORGAN TRANSPLANT COMPLICATIONS
Phase: PHASE3 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Experimental cell therapy targets dangerous virus in vulnerable patients
Disease control Recruiting nowThis study is testing whether an experimental cell therapy called tabelecleucel can help control diseases caused by the Epstein-Barr virus in people with weakened immune systems. The trial includes 190 participants who have developed serious conditions like lymphomas or sarcomas …
Matched conditions: SOLID ORGAN TRANSPLANT COMPLICATIONS
Phase: PHASE2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC